These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY. Cancer; 2012 Oct 01; 118(19):4725-36. PubMed ID: 22359112 [Abstract] [Full Text] [Related]
13. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ. Biomed Res Int; 2021 Oct 01; 2021():6670367. PubMed ID: 34337041 [Abstract] [Full Text] [Related]
19. Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features. Zou X, Xu Q, You R, Yin G. Cancer Med; 2023 May 01; 12(10):11315-11333. PubMed ID: 36951443 [Abstract] [Full Text] [Related]